Rocket Pharmaceuticals
RCKT
RCKT
177 hedge funds and large institutions have $3.4B invested in Rocket Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 52 increasing their positions, 49 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3.72% more ownership
Funds ownership: 100.12% → 103.84% (+3.7%)
6% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 49
36% less call options, than puts
Call options by funds: $7.09M | Put options by funds: $11.1M
Holders
177
Holding in Top 10
7
Calls
$7.09M
Puts
$11.1M
Top Buyers
| 1 | +$117M | |
| 2 | +$66.2M | |
| 3 | +$65.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$61.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.8M |
Top Sellers
| 1 | -$35.4M | |
| 2 | -$30.2M | |
| 3 | -$26.2M | |
| 4 |
FM
Frazier Management
Seattle,
Washington
|
-$19.7M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$16.5M |